Allogene Therapeutics Growth Metrics (2019-2025) | ALLO

Growth Metrics Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -21.86M3.28M-15.78M-36.25M-10.12M-22.18M4.09M-3.91M2.46M
EBITDA Margin Growth (3y) -29.52M
EBITDA Margin (QoQ) -16.17M0.21M15.97M-21.87M8.98M-18.86M-4.50M4.26M-3.08M7.41M-12.50M10.62M
EBIT Margin Growth (1y) -20.51M4.17M-14.71M-37.08M-12.51M-24.64M1.93M-3.45M1.44M
EBIT Margin Growth (3y) -31.58M
EBIT Margin (QoQ) -16.13M0.29M15.85M-20.52M8.55M-18.59M-6.52M4.04M-3.58M7.97M-11.89M8.94M
EBT Margin Growth (1y) -20.38M4.08M-14.42M-36.01M-11.95M-22.97M4.37M-1.53M3.22M
EBT Margin Growth (3y) -29.11M
EBT Margin (QoQ) -15.99M0.23M15.77M-20.39M8.47M-18.27M-5.83M3.67M-2.55M9.08M-11.73M8.42M
Enterprise Value Growth (1y) 53.24%-79.06%-67.79%-56.05%-41.93%34.67%42.51%44.76%35.81%16.54%-14.22%-13.12%-4.94%-0.30%15.70%13.27%18.33%9.62%37.37%34.82%27.24%38.57%13.50%
Enterprise Value Growth (3y) 24.76%0.80%-3.28%0.84%1.49%18.23%17.89%18.47%18.06%8.88%15.51%13.84%14.56%17.73%22.99%
Enterprise Value Growth (5y) 18.25%2.41%10.27%11.23%10.69%21.21%21.41%
Enterprise Value (QoQ) 52.34%0.23%-5.84%7.09%-82.51%6.52%1.56%15.50%15.99%17.73%5.42%1.80%-9.23%-12.59%6.32%8.91%-4.40%5.38%3.61%14.23%-15.53%34.43%-0.31%4.25%2.47%7.66%
FCF Margin Growth (1y) -17.97M4.56M-7.07M-24.53M-4.57M-21.39M-7.51M-1.13M-2.85M
FCF Margin Growth (3y) -25.40M
FCF Margin (QoQ) -11.40M0.76M10.65M-17.98M11.12M-10.87M-6.80M1.98M-5.69M3.00M-0.41M0.25M
Interest Coverage Ratio Growth (1y) 81.81%
Interest Coverage Ratio (QoQ) -4.05%41.80%51.22%38.43%
Net Margin Growth (1y) -20.38M4.08M-14.42M-36.01M-11.95M-22.97M4.37M-1.53M3.22M
Net Margin Growth (3y) -29.11M
Net Margin (QoQ) -15.99M0.23M15.77M-20.39M8.47M-18.27M-5.83M3.67M-2.55M9.08M-11.73M8.42M
Operating Margin Growth (1y) -20.51M4.17M-14.71M-37.08M-12.51M-24.64M1.93M-3.45M1.44M
Operating Margin Growth (3y) -31.58M
Operating Margin (QoQ) -16.13M0.29M15.85M-20.52M8.55M-18.59M-6.52M4.04M-3.58M7.97M-11.89M8.94M
Return on Assets Growth (1y) 6.0010.003.00-3.004.00-3.00-3.00-3.00-22.00-22.00-22.00-18.00-7.00-1.003.00-1.001.00-2.00-5.00-2.00
Return on Assets Growth (3y) -12.00-15.00-22.00-24.00-25.00-26.00-22.00-22.00-28.00-25.00-24.00-21.00
Return on Assets Growth (5y) -18.00-18.00-24.00-26.00
Return on Assets (QoQ) -3.006.004.00-1.001.00-2.00-2.006.00-5.00-2.00-2.00-13.00-6.00-1.002.00-2.001.002.00-1.000.00M-3.00-1.002.00
Return on Capital Employed Growth (1y) 7.0013.004.00-3.005.00-3.00-3.00-3.00-24.00-26.00-26.00-21.00-9.00-2.001.00-3.000.00M-3.00-6.00-3.00
Return on Capital Employed Growth (3y) -12.00-16.00-25.00-27.00-28.00-31.00-28.00-27.00-34.00-31.00-30.00-27.00
Return on Capital Employed Growth (5y) -21.00-21.00-30.00-32.00
Return on Capital Employed (QoQ) -3.007.004.00-2.002.00-1.00-2.006.00-5.00-2.00-2.00-15.00-7.00-2.003.00-3.000.00M1.00-1.000.00M-3.00-2.002.00
Return on Equity Growth (1y) 7.0012.003.00-4.004.00-4.00-5.00-5.00-28.00-30.00-30.00-24.00-10.00-1.003.00-2.00-1.00-5.00-9.00-7.00
Return on Equity Growth (3y) -17.00-22.00-32.00-33.00-34.00-35.00-32.00-31.00-38.00-36.00-36.00-33.00
Return on Equity Growth (5y) -28.00-28.00-38.00-42.00
Return on Equity (QoQ) -4.008.004.00-1.001.00-1.00-2.006.00-6.00-2.00-3.00-17.00-8.00-2.004.00-3.000.00M2.00-2.00-1.00-4.00-2.000.00M
Return on Invested Capital (QoQ) -4.009.005.00
Return on Sales Growth (1y) -0.20M0.04M-0.14M-0.36M-0.12M-0.23M0.04M-0.02M0.03M-0.06M-0.38M-0.78M
Return on Sales Growth (3y) -0.29M-0.25M-0.48M-1.15M
Return on Sales (QoQ) -0.16M0.00M0.16M-0.20M0.08M-0.18M-0.06M0.04M-0.03M0.09M-0.12M0.08M-0.12M-0.23M-0.51M